Mac Shine

Associate professor of computational systems neurobiology
University of Sydney

Mac Shine is associate professor of computational systems neurobiology in the Brain and Mind Centre at the University of Sydney in Australia. His lab focuses on mapping mechanistic neurobiological neural models to dynamical network signatures estimated from functional neuroimaging data.

Shine completed his Ph.D. in cognitive neuroscience at the University of Sydney. As a graduate student, he helped to refine the neural mechanisms of non-motor symptoms of Parkinson’s disease. As a postdoctoral fellow at Stanford University in California, Shine developed innovative approaches for tracking whole-brain network dynamics from noninvasive functional neuroimaging data. In 2017, he returned to the University of Sydney, where he runs a diverse research lab that creates neurobiological models of cognitive function. He is a joint National Health and Medical Research Council/Bellberry fellow.

From this contributor

Explore more from The Transmitter

Grid of human brain scans.

Dose, scan, repeat: Tracking the neurological effects of oral contraceptives

We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.

By Carina Heller
20 January 2025 | 7 min read
Colorful illustration of a latticework of proteins.

Cracking the code of the extracellular matrix

Despite evidence for a role in plasticity and other crucial functions, many neuroscientists still view these proteins as “brain goop.” The field needs technical advances and a shift in scientific thinking to move beyond this outdated perspective.

By Anna Victoria Molofsky
17 January 2025 | 5 min read
A repeated DNA strand extends farther from the left side of the image with each iteration.

Huntington’s disease gene variants past a certain size poison select cells

The findings—providing “the next step in the whole pathway”—help explain the disease’s late onset and offer hope that it has an extended therapeutic window.

By Angie Voyles Askham
16 January 2025 | 6 min read